Caribou Biosciences, Inc.
CRBU
$1.97
$0.063.14%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.85% | 49.08% | -35.28% | -12.68% | -2.32% |
| Total Depreciation and Amortization | 8.08% | -45.93% | 0.17% | -1.60% | 0.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.83% | -86.98% | 570.53% | 14.63% | -14.50% |
| Change in Net Operating Assets | 232.51% | -354.33% | 137.03% | 65.23% | -52.34% |
| Cash from Operations | 17.32% | 10.87% | 23.06% | -3.54% | -8.60% |
| Capital Expenditure | 287.83% | 72.49% | 59.88% | -101.16% | 23.03% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 61.90% | -55.16% | -51.50% | 206.80% | -39.56% |
| Cash from Investing | 65.61% | -54.86% | -51.33% | 209.99% | -39.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,369.31% | 4,516.67% | -98.72% | -87.89% | 1,483.20% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,369.31% | 4,516.67% | -98.72% | -87.89% | 1,483.20% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 108.65% | -233.42% | -132.12% | 183.71% | -165.89% |